此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

GENERATE - 下一代妇科生态手术 - 妇科适应症的机器人辅助手术 (GENERATE)

2026年11月2日 更新者:Intuitive Surgical

GENERATE - Next GENERATION of GynEcological Surgery - 妇科适应症的机器人辅助手术 - 一项前瞻性、非介入性、多中心、上市后临床研究

GENERATE - Next GENERATion of GynEcological Surgery - Robotic Assisted Surgery in Gynecological Indications

Generate real-world evidence in the use of the da Vinci Surgical Systems for gynecological indications within the German health care system.

研究概览

详细说明

A prospective, non-interventional, multi-center, post market clinical study.

研究类型

观察性的

注册 (估计的)

1250

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

研究联系人备份

学习地点

      • Berlin、德国、13353
        • 主动,不招人
        • Charité - Universitätsmedizin Berlin - Klinik für Gynäkologie
      • Bochum、德国、44791
        • 主动,不招人
        • Augusta-Kranken-Anstalt Bochum
      • Coburg、德国、96450
        • 主动,不招人
        • Sana Kliniken Coburg
      • Cologne、德国、50935
        • 终止
        • St. Elisabeth-Krankenhaus Köln-Hohenlind
      • Essen、德国、45147
        • 主动,不招人
        • Universitätsklinikum Essen
      • Frankfurt am Main、德国、60431
        • 主动,不招人
        • Agaplesion Markus Krankenhaus Frankfurt am Main
      • Freiburg im Breisgau、德国、79106
        • 招聘中
        • Universitätsklinikum Freiburg - Klinik für Frauenheilkunde
        • 接触:
          • Markus Hübner, Prof. Dr.
      • Greifswald、德国、17475
      • Höxter、德国、37671
        • 主动,不招人
        • St. Ansgar Krankenhaus Höxter
      • Kiel、德国、24105
        • 主动,不招人
        • Universitätsklinikum Kiel
      • Nuremberg、德国、90419
        • 主动,不招人
        • Klinikum Nürnberg Nord / Klinik für Frauenheilkunde
      • Schwerin、德国、19055
        • 主动,不招人
        • Helios Kliniken Schwerin
      • Tübingen、德国、72076
        • 主动,不招人
        • Universitätsklinikum Tübingen - Frauenklinik
    • Free and Hanseatic City of Hamburg
      • Hamburg、Free and Hanseatic City of Hamburg、德国、22457
        • 主动,不招人
        • Albertinen Krankenhaus Hamburg
    • Hesse
      • Wiesbaden、Hesse、德国、65189
        • 主动,不招人
        • St. Josefs-Hospital Wiesbaden

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

女性

取样方法

概率样本

研究人群

Patients with gynecological disease that may be treated by surgical intervention.

描述

Key Inclusion Criteria:

  • Woman with 18 years of age or older
  • Patient is willing to participate and to comply with the study procedures as demonstrated by signing the informed consent
  • Patient is a candidate for a gynecological procedure to be performed with the Intuitive Surgical System

Key Exclusion Criteria:

  • Life expectancy of less than 1 year
  • Pregnancy, or positive pregnancy test for women prior to menopause or breastfeeding women
  • Current participation in a clinical study, if not pre-approved by Intuitive
  • Individuals who are unable to fully understand all aspects of the study that are relevant to the decision to participate (mentally or verbally), or who could be manipulated or unduly influenced as a result of a compromised position, expectation of benefits or fear of retaliation

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 观测模型:COHORT
  • 时间观点:PROSPECTIVE

队列和干预

团体/队列
干预/治疗
da Vinci Patients

Consecutive enrollment of patients with indications of interest and having a da Vinci robotic-assisted surgery

Robotic-assisted surgery (da Vinci)

Epidemiological Data Audit

Extended data collection on patients with indications of interest, eligible for a robotic-assisted surgery, but treatment choice was not a da Vinci surgery

Non-da Vinci Surgery

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Number of complications related to the surgery up to 30 days
大体时间:30 days

Describe the number of complications related to the surgery up to 30 days; adverse events as documented during the first 30 days will be classified as four different levels of causality to the surgery (not related, possible, probable and causal relationship). Descriptive analysis will be performed.

30 days
Describe the number of patient-reported outcomes up to 12 months
大体时间:12 months

Describe the patient-reported outcomes up to 12 months; descriptive analysis will be performed on the data directly reported via the patients (patient questionnaires); information included are number of complications, re-hospitalizations, re-operations, disease recurrence, disease remission, new disease diagnosis and pain status including pain medication

12 months
Characterize the treatment decision as reported by the treating physician
大体时间:30 days

Characterize the treatment decision per data provided by the treating physician (within the study database) including the rationale given for the treatment decision (e.g., age of the patient or co-morbidity); number of treatment decisions, e.g., for surgical therapy (open surgery or minimal-invasive therapy), watchful waiting, or treatment with medication will be described; descriptive analysis will be performed

30 days

次要结果测量

结果测量
措施说明
大体时间
Investigate the impact of patient characteristics on surgery
大体时间:30 days

Descriptive analysis of patient characteristics such as age on surgery (e.g., duration of surgery, instrument usage)

30 days
Investigate the impact of patient characteristics on clinical outcome
大体时间:30 days

Descriptive analysis of patient characteristics such as age on clinical outcome (e.g., re-operation)

30 days
Investigate the impact of patient characteristics on complications
大体时间:30 days

Descriptive analysis of patient characteristics such as age on complication (number of complications reported during and after the surgery)

30 days
Describe the impact from surgery to the patient's quality of life and function
大体时间:12 months

Describe the impact from surgery to the patient's quality of life and function by comparing the baseline quality of life and functional status with the post-operative status (post-operative day 1-3, 30 days, 90 days, 6 months and 12 months)

12 months
Describe the number of Intuitive instruments used per procedure and patient characteristics
大体时间:30 days

Describe the number of Intuitive instruments used per procedure and patient characteristics; descriptive analysis will be performed on the number of instruments used per specific procedure and patient

30 days
Describe the number of disease recurrence and re-operation at final patient follow-up
大体时间:12 months

Describe the number disease recurrence and re-operation at final patient follow-up; descriptive analysis will be performed

12 months
Describe the number of conversion per procedure and patient characteristics
大体时间:30 days

Describe the number conversion per procedure and patient characteristics; descriptive analysis will be performed

30 days
Describe the impact of surgeon experience on surgical times (duration of surgery per treating surgeon)
大体时间:30 days

Describe the impact of surgeon experience on surgical times, descriptive analysis will be performed on the surgical times (duration of surgery) per treating surgeon

30 days
Describe the impact of surgeon experience on clinical outcome (number of clinical outcomes per treating surgeon)
大体时间:30 days

Describe the impact of surgeon experience on clinical outcome; descriptive analysis will be performed, e.g., on number of re-operation or re-hospitalization per treating surgeon

30 days
Describe the impact of surgeon experience on complications (number of events per surgeon)
大体时间:30 days

Describe the impact of surgeon experience on complications; descriptive analysis will be performed on number of adverse events per treating surgeon

30 days

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Ingolf Juhasz-Böss, Prof. Dr.、University Hospital Freiburg

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2023年10月25日

初级完成 (估计的)

2028年2月1日

研究完成 (估计的)

2028年7月1日

研究注册日期

首次提交

2023年5月2日

首先提交符合 QC 标准的

2023年5月10日

首次发布 (实际的)

2023年5月22日

研究记录更新

最后更新发布 (实际的)

2026年11月4日

上次提交的符合 QC 标准的更新

2026年11月2日

最后验证

2026年11月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

是的

在美国制造并从美国出口的产品

是的

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅